Discover reporting you’re not seeing from biased, mainstream media outlets.
Using our real-time Media Miss™ tool powered by Ground News, we spotlight stories that right-leaning and left-leaning news outlets aren’t covering to bring you a complete picture of the news.
Media Landscape
Click on bars to see headlines
36 total sources
-
No coverage from Far Left sources 0 sources
-
No coverage from Left sources 0 sources
-
See Hide headlines from Lean Left sources 6 sources
-
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
The Independent -
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Bloomberg -
Weight loss drug Wegovy cuts risk of heart problems, maker says
Star Tribune -
Wegovy weight loss drug set for use on NHS also cuts heart attack and stroke risk, trial shows
iNews -
Wegovy reduces risk of heart attacks, strokes, and death by up to 20%, new study finds
INSIDER -
Weight loss drug Wegovy, results beyond expectations in an advanced clinical trial: reduces risk of cardiovascular disease by 20%
Hot News
-
-
See Hide headlines from Center sources 15 sources
-
Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Reuters -
Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
Hindustan Times -
Novo Nordisk shares pop after key trial data shows Wegovy cuts risk of heart attack or stroke by 20%
CNBC -
Wegovy: Weight loss injections can lower heart attack and stroke risk in obese people by a fifth, research suggests
Sky News UK -
Weight-Loss Drug Wegovy Lowers Major Heart Disease Risk By 20% According To Trial Data—Novo Nordisk Shares Surge
Forbes -
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
Fortune -
Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Devdiscourse -
Wegovy cuts heart attack and stroke risk, study shows
NY1 -
INSTANT VIEW-Novo’s obesity drug cuts risk of heart disease by 20% in study
WTVB -
Novo Nordisk’s weight loss jab Wegovy cuts risk of stroke by 20%
Financial Times -
Novo Nordisk hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20% By Investing.com
Investing.com -
Weight Loss Drug Wegovy May Help Prevent Heart Attacks
WebMD -
Popular weight loss drug Wegovy also found to lower the risk of heart attacks, strokes
Good Morning America -
Novo's obesity drug Wegovy lowers cardiovascular risk by 20%, landmark trial finds
STAT -
Weight loss drug Wegovy can reduce heart attack risk, study says
Straight Arrow News
-
-
See Hide headlines from Lean Right sources 5 sources
-
Weight loss jab ‘cuts risk of heart attacks and strokes’
The Telegraph -
Weight-loss drug Wegovy cuts heart attack risk in people with obesity, study shows
National Post -
Weight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study shows
Alabama Live -
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Wall Street Journal -
Novo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows
Fox Business
-
-
See Hide headlines from Right sources 2 sources
-
No coverage from Far Right sources 0 sources
Other (sources without bias rating):
-
See Hide headlines from Other sources 8 sources
-
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
Shropshire Star -
Study: Wegovy drug reduces risk of heart disease by 20 percent
handelsblatt.com -
Wegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Het Nieuwsblad -
Wegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Het Belang van Limburg -
Weight loss drug Wegovy found to lower risk of heart attack, stroke
Western Iowa Today 96.5 KSOM KS 95.7 -
Wegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Gazet van Antwerpen -
Novo Nordisk Says Weight-Loss Drug Cuts Risk of Cardiovascular Events
Morningstar.com -
Study: Wegovy slimming injection reduces risk of heart disease by 20 percent
Salzburger Nachrichten
-
Powered by Ground News™
